News
-
-
-
COMMUNIQUÉ DE PRESSE
Inside Information / Other news releases
CIC Market Solutions initiates buy coverage of ABIONYX Pharma. ABIONYX Pharma, a next-generation biopharma dedicated to innovative biomedicines based on recombinant apoA-I for severe inflammatory diseases, receives Buy recommendation from CIC Market Solutions -
-
-
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
Heidelberg Pharma AG reports successful business performance in 2024 with improved financial figures including clinical trial results for HDP-101 in multiple myeloma and upcoming study for HDP-102. Financial outlook and strategy for 2025 highlighted -
COMMUNIQUÉ DE PRESSE
SoftwareOne publishes agenda for Extraordinary General Meeting and provides update on Crayon combination
SoftwareOne Holding AG publishes agenda for Extraordinary General Meeting and provides update on Crayon combination in Switzerland, announcing proposed changes to Board of Directors and regulatory approvals -
COMMUNIQUÉ DE PRESSE
FUCHS concludes financial year 2024 successfully with new EBIT-high
FUCHS concludes successful financial year 2024 with new EBIT-high, reaching EUR 434 million. Earnings per share up by 10%. Plans for 2025 include sales revenues of EUR 3.7 billion and EBIT around EUR 460 million -
-